InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Entera Bio Ltd.

ENTX Clue Score36
Israel Fiscal year ends December CIK 0001638097
$2.66 +6.40% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.66 −42.17% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 28 Jun 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−5.4Net income−1.2EPS, diluted0.78Fiscal year 2017Operating income−11.3Net income−11.2EPS, diluted2.49Fiscal year 2018Revenue0.5Operating income−10.9Net income−10.3EPS, diluted1.31Fiscal year 2019Revenue0.2 −52.8%Operating income−11.5Net income−10.8EPS, diluted0.89Fiscal year 2020Revenue0.4 +54.7%Operating income−11.2Net income−11.2EPS, diluted0.55Fiscal year 2021Revenue0.6 +56.4%Operating income−12.2Net income−12.2EPS, diluted0.47Fiscal year 2022Revenue0.1 −76.5%Operating income−13.0Net income−13.1EPS, diluted0.45Fiscal year 2023Revenue0.0 −100.0%Operating income−8.9Net income−8.9EPS, diluted0.31Fiscal year 2024Revenue0.2Operating income−9.6Net income−9.5EPS, diluted0.25Fiscal year 2025Revenue0.0 −76.8%Operating income−11.5Net income−11.4EPS, diluted0.25
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 0.5 0.2 0.4 0.6 0.1 0.0 0.2 0.0
Growth −52.8% +54.7% +56.4% −76.5% −100.0% −76.8%
Operating income −5.4 −11.3 −10.9 −11.5 −11.2 −12.2 −13.0 −8.9 −9.6 −11.5
Net income −1.2 −11.2 −10.3 −10.8 −11.2 −12.2 −13.1 −8.9 −9.5 −11.4
Growth
EPS, diluted 0.78 2.49 1.31 0.89 0.55 0.47 0.45 0.31 0.25 0.25

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Operating margin−2,172.2%Net margin−2,060.8%Free cash flow margin−1,972.8%Fiscal year 2019Operating margin−4,853.4%Net margin−4,574.2%Free cash flow margin−3,796.2%Fiscal year 2020Gross margin17.8%Operating margin−3,059.7%Net margin−3,072.9%Free cash flow margin−2,906.8%Fiscal year 2021Gross margin34.7%Operating margin−2,139.6%Net margin−2,134.3%Free cash flow margin−1,590.2%Fiscal year 2022Gross margin24.6%Operating margin−9,714.2%Net margin−9,754.5%Free cash flow margin−9,362.7%Fiscal year 2023Fiscal year 2024Gross margin5.0%Operating margin−5,295.6%Net margin−5,271.3%Free cash flow margin−3,768.5%Fiscal year 2025Gross margin0.0%Operating margin−27,450.0%Net margin−27,235.7%Free cash flow margin−17,802.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a 17.8% 34.7% 24.6% n/a 5.0% 0.0%
Operating margin n/a n/a −2,172.2% −4,853.4% −3,059.7% −2,139.6% −9,714.2% n/a −5,295.6% −27,450.0%
Net margin n/a n/a −2,060.8% −4,574.2% −3,072.9% −2,134.3% −9,754.5% n/a −5,271.3% −27,235.7%
Free cash flow margin n/a n/a −1,972.8% −3,796.2% −2,906.8% −1,590.2% −9,362.7% n/a −3,768.5% −17,802.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−3.1Capital expenditure−0.0Free cash flow−3.2Fiscal year 2017Operating cash flow−4.5Capital expenditure−0.1Free cash flow−4.6Fiscal year 2018Operating cash flow−9.8Capital expenditure−0.1Free cash flow−9.9Fiscal year 2019Operating cash flow−8.9Capital expenditure−0.0Free cash flow−9.0Fiscal year 2020Operating cash flow−10.6Capital expenditure−0.1Free cash flow−10.6Fiscal year 2021Operating cash flow−9.1Capital expenditure−0.0Free cash flow−9.1Fiscal year 2022Operating cash flow−12.5Capital expenditure−0.0Free cash flow−12.5Fiscal year 2023Operating cash flow−7.3Capital expenditure−0.0Free cash flow−7.3Fiscal year 2024Operating cash flow−6.8Capital expenditure−0.0Free cash flow−6.8Fiscal year 2025Operating cash flow−7.4Capital expenditure−0.1Free cash flow−7.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −3.1 −4.5 −9.8 −8.9 −10.6 −9.1 −12.5 −7.3 −6.8 −7.4
Capital expenditure −0.0 −0.1 −0.1 −0.0 −0.1 −0.0 −0.0 −0.0 −0.0 −0.1
Free cash flow −3.2 −4.6 −9.9 −9.0 −10.6 −9.1 −12.5 −7.3 −6.8 −7.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash4.2Shareholders’ equity−25.2Fiscal year 2017Cash11.7Total debt3.9Net cash (debt)7.9Shareholders’ equity−31.6Fiscal year 2018Cash7.5Shareholders’ equity10.1Fiscal year 2019Cash15.2Shareholders’ equity13.8Fiscal year 2020Cash8.6Shareholders’ equity7.5Fiscal year 2021Cash24.9Shareholders’ equity22.6Fiscal year 2022Cash12.3Shareholders’ equity11.8Fiscal year 2023Cash11.0Shareholders’ equity10.4Fiscal year 2024Cash8.7Shareholders’ equity8.1Fiscal year 2025Cash7.1Shareholders’ equity13.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 4.2 11.7 7.5 15.2 8.6 24.9 12.3 11.0 8.7 7.1
Total debt n/a 3.9 n/a n/a n/a n/a n/a n/a n/a n/a
Net cash (debt) n/a 7.9 n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders’ equity −25.2 −31.6 10.1 13.8 7.5 22.6 11.8 10.4 8.1 13.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017† 31 Dec 2017 FY2018† 31 Dec 2018 FY2019† 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a n/a 0.5 0.2 0.4 0.6 0.1 0.0 0.2 0.0
Growth −52.8% +54.7% +56.4% −76.5% −100.0% −76.8%
n/a n/a n/a 0.2 0.3 0.4 0.1 0.0 0.2 0.0
n/a n/a n/a n/a 0.1 0.2 0.0 0.0 0.0 0.0
Growth +204.6% −83.3% −100.0% −100.0%
2.6 2.8 8.5 7.2 6.4 n/a n/a n/a n/a n/a
2.7 8.6 2.8 4.3 4.9 n/a n/a n/a 0.3 0.4
−5.4 −11.3 −10.9 −11.5 −11.2 −12.2 −13.0 −8.9 −9.6 −11.5
Growth
n/a n/a −10.3 −10.8 −11.2 −12.2 −12.9 −8.9 −9.5 −11.4
n/a n/a n/a n/a 0.0 −0.1 0.1 0.0 0.0 0.0
−1.2 −11.2 −10.3 −10.8 −11.2 −12.2 −13.1 −8.9 −9.5 −11.4
Growth
Per share
0.27 2.49 1.30 0.89 0.54 0.47 0.45 0.31 0.25 0.25
0.78 2.49 1.31 0.89 0.55 0.47 0.45 0.31 0.25 0.25
Growth +219.2% −47.4% −32.1% −38.2% −14.5% −4.3% −31.1% −19.4% +0.0%
4.5 4.5 8.0 12.1 18.4 26.1 28.8 29.0 37.7 46.2
6.8 4.5 8.0 12.1 18.6 26.1 28.8 29.0 37.7 46.2
Growth −33.5% +77.8% +52.1% +52.8% +40.8% +10.2% +0.7% +29.8% +22.7%

† The diluted share count jumps at 2017 and 2018 and 2019 and 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 35.1% a year over five years.
  • Operating margin is down 24,390.3 points on five years ago, at -27,450.0%.
  • A net loss in 10 of 10 years on file.